Raptor Pharmaceutical Inc.
7 Hamilton Landing
Suite 100
Novato
California
94949
United States
Tel: 415-408-6200
Fax: 415-382-8002
Website: http://raptorpharma.com/
Email: info@raptorpharma.com
188 articles about Raptor Pharmaceutical Inc.
-
Raptor Pharmaceutical Inc.l to Present at Upcoming Investor Conference
7/2/2013
-
Raptor Pharmaceutical Inc.'s PROCYSBI Receives Positive Recommendation From CHMP
6/28/2013
-
Raptor Pharmaceutical Inc.'s PROCYSBI Now Commercially Available in the U.S. for Nephropathic Cystinosis Patients
6/19/2013
-
Raptor Pharmaceutical Inc.l to Present at Upcoming Investor Conference
6/12/2013
-
Raptor Pharmaceutical Inc. Reports First Quarter Calendar Year 2013 Financial Results
5/9/2013
-
Raptor Pharmaceutical Inc. Licenses Intellectual Property for Rett Syndrome From French Research Institutes
5/7/2013
-
Raptor Pharmaceutical Inc. Receives FDA Approval for Procysbi
5/2/2013
-
Raptor Pharmaceutical Inc. Reports Financial Results for the Transition Period From September 1, 2012 to December 31, 2012
3/15/2013
-
Raptor Pharmaceutical Inc. Reports First Quarter Fiscal Year 2013 Financial Results
1/10/2013
-
Raptor Pharmaceutical Inc. Release: HealthCare Royalty Partners Commits Over $300 Million in New Investments in December and Over $425 Million in 2012
1/3/2013
-
Raptor Pharmaceutical Inc. Signs $50 Million Loan Agreement With HealthCare Royalty Partners
12/20/2012
-
Raptor Pharmaceutical Inc. Reports Fourth Quarter and Fiscal Year 2012 Financial Results
11/14/2012
-
Raptor Pharmaceutical Inc. to Present at the Lazard Capital Markets 9th Annual Healthcare Conference 2012
11/12/2012
-
Raptor Pharmaceutical Inc. Announces Positive Data on RP103 Extension Study Presented at Kidney Week 2012
11/5/2012
-
Raptor Pharmaceutical Inc. Reports Fiscal Year 2012 Financial Highlights and Program Updates
11/1/2012
-
Raptor Pharmaceutical Inc. Announces Presentation of PROCYSBI (RP103) Extension Study Data at the American Society of Nephrology Annual Meeting
10/17/2012
-
Raptor Pharmaceutical Inc. Obtains Tissue Fibrotic Disease Intellectual Property Related to Cysteamine
10/10/2012
-
Raptor Pharmaceutical Inc. Expands Senior Management
9/11/2012
-
Raptor Pharmaceutical Inc. to Present at the Stifel Nicolaus Healthcare Conference 2012
8/30/2012
-
Raptor Pharmaceutical Inc. to Present at Two Upcoming Investor Conferences
8/7/2012